The invention relates to triazines and the use thereof to inhibit lysophosphatidic acid acyltransferase .beta. (LPAAT-.beta.) activity. The invention further relates to methods of treating cancer using said triazines. The invention also relates to methods for screening for LPAAT-.beta. activity.